Breaking News Instant updates and real-time market news.

ACRS

Aclaris Therapeutics

$24.72

-0.38 (-1.51%)

07:02
12/15/17
12/15
07:02
12/15/17
07:02

Aclaris Therapeutics receives FDA approval for Eskata topical solution, 40%

Aclaris Therapeutics announced that the FDA has approved Eskata topical solution, 40% for the treatment of raised seborrheic keratoses, or SKs. SKs are non-cancerous skin growths that affect more than 83 million American adults and can be an aesthetic skin concern. SKs tend to increase in size and number with age. The condition is more prevalent than acne, psoriasis and rosacea combined. The FDA approval of Eskata is based on two pivotal Phase 3 trials that demonstrated the safety and efficacy of Eskata for the treatment of raised SKs. In these trials, patients received up to two treatments with Eskata, with one at treatment initiation and a second at week three. Patients treated with Eskata were more likely to have all four treated SKs completely cleared after two treatments than patients who received placebo. Treatment with Eskata was generally well tolerated, with the most common side effects being itching, stinging, crusting, swelling, redness and scaling at the site of application.

  • 24

    Dec

ACRS Aclaris Therapeutics
$24.72

-0.38 (-1.51%)

04/26/17
LEER
04/26/17
NO CHANGE
Target $54
LEER
Outperform
Aclaris patent could be worth $15 per share, says Leerink
Leerink analyst Seamus Fernandez believes the A-101 patent announced today by Aclaris Therapeutics could add $15 per share to the company's net present value. The newly allowed patent expires in 2035, 11 years later than the analyst currently assumes loss of exclusivity in seborrheic keratosis. Extending the patent life of A-101 could increase the NPV contribution to $31 per share from $16, Fernandez tells investors in a research note. He keeps an Outperform rating on Aclaris with a $54 price target.
06/16/17
CANT
06/16/17
INITIATION
Target $50
CANT
Overweight
Aclaris Therapeutics initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Louise Chen started Aclaris Therapeutics with an Overweight rating and $50 price target.
09/19/17
CANT
09/19/17
NO CHANGE
Target $50
CANT
Overweight
Public FDA meeting positive for Aclaris, says Cantor
The FDA last Monday conducted a public meeting on alopecia areata patient-focused drug development, Cantor Fitzgerald analyst Louise Chen tells investors in a research note. The meeting was constructive on alopecia as a disease and the need to get drugs approved, the analyst contends. She believes the meeting is a positive for Aclaris Therapeutics, which she notes is working on "several solutions to the problem." Chen has an Overweight rating on Aclaris with a $50 price target.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$271.93

-0.64 (-0.23%)

10:35
05/23/18
05/23
10:35
05/23/18
10:35
Technical Analysis
Technical Take: SPDR S&P 500 ETF falls from highs after first hour »

At time of writing the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$271.93

-0.64 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XGTI

xG Technology

$0.76

(0.00%)

10:35
05/23/18
05/23
10:35
05/23/18
10:35
Hot Stocks
xG Technology awarded $1.4M U.S. Air Force order »

xG Technology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$9.05

-0.5 (-5.24%)

10:35
05/23/18
05/23
10:35
05/23/18
10:35
Options
Frontier Communications put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:33
05/23/18
05/23
10:33
05/23/18
10:33
General news
Crude inventories for week of May 18 »

Crude oil inventories…

QTNA

Quantenna Communications

$15.66

0.72 (4.82%)

, KOOL

Cesca Therapeutics

$0.54

0.0091 (1.71%)

10:33
05/23/18
05/23
10:33
05/23/18
10:33
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

QTNA

Quantenna Communications

$15.66

0.72 (4.82%)

KOOL

Cesca Therapeutics

$0.54

0.0091 (1.71%)

WTI

W&T Offshore

$8.26

-0.09 (-1.08%)

TAST

Carrols Restaurant

$11.70

0.05 (0.43%)

VNDA

Vanda Pharmaceuticals

$17.05

0.5 (3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

INTU

Intuit

$192.03

1.62 (0.85%)

, DSW

DSW

$24.95

-0.69 (-2.69%)

10:32
05/23/18
05/23
10:32
05/23/18
10:32
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

INTU

Intuit

$192.03

1.62 (0.85%)

DSW

DSW

$24.95

-0.69 (-2.69%)

SHAK

Shake Shack

$58.44

0.46 (0.79%)

LTC

LTC Properties

$39.13

-0.32 (-0.81%)

CELG

Celgene

$77.24

0.65 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 03

    Jun

  • 05

    Jun

  • 12

    Jun

  • 13

    Jun

AEE

Ameren

$57.59

0.87 (1.53%)

, GDS

GDS Holdings

$38.91

1.53 (4.09%)

10:32
05/23/18
05/23
10:32
05/23/18
10:32
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

AEE

Ameren

$57.59

0.87 (1.53%)

GDS

GDS Holdings

$38.91

1.53 (4.09%)

JWN

Nordstrom

$47.30

1.51 (3.30%)

FCX

Freeport McMoRan

$16.98

-0.19 (-1.11%)

CELG

Celgene

$77.24

0.65 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

GSHD

Goosehead Insurance

$16.30

0.26 (1.62%)

10:32
05/23/18
05/23
10:32
05/23/18
10:32
Hot Stocks
Goosehead Insurance plans to open corporate office in Chicago »

Personal lines insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$128.43

-0.84 (-0.65%)

10:26
05/23/18
05/23
10:26
05/23/18
10:26
Downgrade
Nordson rating change  »

Nordson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

CELG

Celgene

$77.35

0.76 (0.99%)

10:24
05/23/18
05/23
10:24
05/23/18
10:24
Hot Stocks
Street Fight: Argus sees Celgene risk, but Bernstein thinks sentiment at bottom »

In a research note this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

EVOP

EVO Payments

$0.00

(0.00%)

10:21
05/23/18
05/23
10:21
05/23/18
10:21
Syndicate
Breaking Syndicate news story on EVO Payments »

EVO Payments indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

MRK

Merck

$59.07

0.61 (1.04%)

10:20
05/23/18
05/23
10:20
05/23/18
10:20
Options
Short term call buyers in Merck lead puts 8:1 »

Short term call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

  • 23

    Oct

CWH

Camping World

$20.09

-1.31 (-6.12%)

10:18
05/23/18
05/23
10:18
05/23/18
10:18
Hot Stocks
Camping World slides after reporting change in registered public accounting firm »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVOP

EVO Payments

$0.00

(0.00%)

10:17
05/23/18
05/23
10:17
05/23/18
10:17
Syndicate
EVO Payments indicated to open at $20.80, IPO priced at $16.00 »

EVO Payments (EVOP)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
05/23/18
05/23
10:17
05/23/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
05/23/18
05/23
10:16
05/23/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWH

Camping World

$20.20

-1.2 (-5.61%)

10:13
05/23/18
05/23
10:13
05/23/18
10:13
Hot Stocks
Camping World slides after reporting change in registered public accounting firm »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$15.97

0.03 (0.19%)

10:10
05/23/18
05/23
10:10
05/23/18
10:10
Options
Bullish option flow in Kinder Morgan »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$36.41

0.04 (0.11%)

10:05
05/23/18
05/23
10:05
05/23/18
10:05
Options
JD.com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$68.97

-2.69 (-3.75%)

10:04
05/23/18
05/23
10:04
05/23/18
10:04
Technical Analysis
Technical Take: Xilinx falls after investor day »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:03
05/23/18
05/23
10:03
05/23/18
10:03
General news
New Home Sales data reported »

April New Home Sales at…

TIF

Tiffany

$117.76

15.5 (15.16%)

10:01
05/23/18
05/23
10:01
05/23/18
10:01
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

MGM

MGM Resorts

$31.57

-0.005 (-0.02%)

09:55
05/23/18
05/23
09:55
05/23/18
09:55
Options
MGM Resorts put volume heavy and directionally bearish »

Bearish flow noted in MGM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$116.41

14.15 (13.84%)

, RL

Ralph Lauren

$126.98

10.31 (8.84%)

09:55
05/23/18
05/23
09:55
05/23/18
09:55
Options
Early notable gainers among liquid option names on May 23rd »

Notable gainers among…

TIF

Tiffany

$116.41

14.15 (13.84%)

RL

Ralph Lauren

$126.98

10.31 (8.84%)

LOW

Lowe's

$92.09

6.35 (7.41%)

URBN

Urban Outfitters

$42.69

1.48 (3.59%)

AAP

Advance Auto Parts

$117.04

1.72 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 07

    Jun

  • 26

    Jun

PLAB

Photronics

$9.30

0.25 (2.76%)

09:55
05/23/18
05/23
09:55
05/23/18
09:55
Conference/Events
Photronics to hold an analyst and investor event »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.